Study Stopped
Evolution of the COVID19 pandemic with subsequent spread to all areas of clinical care severely affected the number of potential participants that were able to safely participate in the study.
Nasal Bridge Pressure Injury Prevention
1 other identifier
interventional
12
1 country
1
Brief Summary
The primary goal of this study is to explore whether applying the Mepilex foam on the nasal bridge directly between the skin and the N95 mask will prevent nasal bridge pressure injury among nursing staff, secondary to long-term ( \>8+ hours) wear time. The secondary goal is to evaluate if using the Mepilex maintains the seal of the mask.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedStudy Start
First participant enrolled
March 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2022
CompletedMay 19, 2022
May 1, 2022
10 months
February 16, 2021
May 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants with Pressure Injury Prevention
Researchers will count the number of participants with and without injury on the nasal bridge directly between the skin and the N95 mask
48 hours
Secondary Outcomes (1)
Number of Participants that Maintain Mask Seal Integrity
12 hours
Study Arms (2)
Intervention Group
EXPERIMENTALControl Group
NO INTERVENTIONInterventions
Mepilex foam will be directly applied on the nasal bridge directly between the skin and the N95 mask.
Eligibility Criteria
You may qualify if:
- The sample will consist of nursing staff working on non-COVID units, including: Medical Surgical Units, Operating Rooms or Ambulatory Care- Labor and Delivery Unit, Maternity Unit and Medical Oncology Unit, at NewYork-Presbyterian (NYP) Lawrence Hospital.
You may not qualify if:
- Nurses working in the Emergency Department, Intensive Care Unit or a unit with a focus on the exposed COVID-19 population
- Non-clinical nurses, volunteer or agency registered nurses
- Known history of skin breakdown or damage to the nasal bridge
- History of skin-related conditions including (acne vulgaris, Psoriasis, Herpetic lesions to mouth, nasal areas)
- History of surgery to nasal bridge
- Pregnant nurses in their third trimester
- History of respiratory extended respirator use in addition to the hours collected in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Irving Medical Center/NYP
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hazel Holder, MSN, RN, ACCNS-AG, CCRN
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single-blind design
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2021
First Posted
February 21, 2021
Study Start
March 23, 2021
Primary Completion
January 4, 2022
Study Completion
January 4, 2022
Last Updated
May 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
Coded participant data will be made available to future researchers with a goal to replicate this study and add to the body of nursing knowledge